Related Experiment Video
Updated: Feb 26, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Mycoplasma pneumoniae-associated Hepatitis without Lung Involvement.
Han Taek Jeong1, Jae Young Oh1, Jung Eun Song1
1Division of Gastroenterology, Department of Internal Medicine, Daegu Catholic University Medical Center, Catholic University of Daegu School of Medicine, Daegu, Korea.
Mycoplasma pneumoniae can cause acute hepatitis, even without lung symptoms. Early macrolide treatment rapidly improved this rare extrapulmonary manifestation in a patient.
Area of Science:
- Infectious Diseases
- Hepatology
- Pulmonology
Background:
- Mycoplasma pneumoniae is a common cause of respiratory infections.
- Extrapulmonary manifestations of Mycoplasma pneumoniae are known but typically involve cardiovascular, dermatological, musculoskeletal, and hematological systems.
- Acute hepatitis as an isolated presentation of Mycoplasma pneumoniae in adults is rare.
Observation:
- A 32-year-old male presented with fever, chills, myalgia, and headache.
- Biochemical analysis revealed severely impaired liver function and leukopenia.
- Laboratory tests and liver biopsy confirmed a hepatocellular pattern of acute hepatitis.
Findings:
- The patient was diagnosed with Mycoplasma pneumoniae-associated acute hepatitis.
- Hepatocellular injury pattern was identified.
- Rapid clinical and laboratory improvement was observed following macrolide treatment.
Implications:
- Mycoplasma pneumoniae should be considered in the differential diagnosis of acute hepatitis, particularly when lung or other extrapulmonary involvement is absent.
- Prompt diagnosis and treatment with macrolides can lead to rapid recovery.
- This case highlights the diverse clinical spectrum of Mycoplasma pneumoniae infections.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

